Low dose atropine eye drops safe and effective for short-sightedness in children, clinical trial suggests
A clinical trial published in The BMJ indicates that low-concentration atropine eye drops are a safe and effective treatment for slowing myopia progression in UK children. While the effects are modest, researchers suggest the drops are a valuable addition to existing optical interventions.
Why it matters
Myopia rates are rising globally, leading to increased healthcare costs and long-term vision complications, making effective non-surgical treatments highly significant for public health.
edited by Sadie Harley , reviewed by Robert Egan
The article reports on peer-reviewed medical research findings without emotive language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in